Maddy is the Medical Business Development Manager at Stratasys Inc. and Stratasys Direct. She collaborates with healthcare providers and device manufacturers to identify applications where additive manufacturing (3D printing) can drive clinical and operational improvements. Some specific areas of focus to date have been clinical simulations, pre-surgical planning, and custom tooling using additive technologies. Maddy is passionate about expanding access to advanced manufacturing solutions and advancing patient care through the adoption of precision 3D printing technologies in the medical field
As 3D printing becomes more deeply integrated into modern healthcare, it’s opening new doors for personalized care and medical innovation. Patient-specific surgical guides, anatomical models, dental appliances, orthotics, and other devices can now be produced faster and more precisely than ever before. But when these 3D printed parts are intended for use in or near the human body, innovation alone isn’t enough. Safety is non-negotiable.
To be clinically viable, 3D printed medical parts must meet two critical requirements: biocompatiblity and the ability to be safely sterilized. These aren’t just regulatory hurdles – they're key to making sure a part made from medical-grade 3d printing materials can come into contact with the human body and be used in sterile environments without putting patients at risk.
This article breaks down what these terms mean in the world of additive manufacturing (AM), how to align with standards like ISO 10993, and why success depends not just on what material you use, but how you use it – from design to delivery.
Biocompatibility refers to the ability of a material to perform its intended function without causing harm to the human body. This means it must not trigger cytotoxic (cell-killing), allergic, inflammatory, or immunological responses when in contact with skin, tissue, mucosal membranes, or fluids.
The global standard used to evaluate biocompatibility is ISO 10993, which outlines various biological risk assessments based on how the material will be used in the body, and for how long.
These evaluations are crucial for anyone working with biocompatible 3D printing materials in medical or dental applications, especially for those producing sterile medical parts with additive manufacturing.
ISO 10993 defines three contact durations that help determine required testing:
The combination of duration and anatomical contact site determines what testing must be performed.
Contact Type |
Common Applications |
Contact Site |
Duration |
Typical Testing |
Surface Devices |
Splints, external braces |
Intact skin |
Limited/Prolonged |
Irritation, sensitization |
External Communicating Devices |
Dental trays, surgical tools |
Mucosal membranes, indirect blood contact |
Limited/Prolonged |
Cytotoxicity, sensitization, hemocompatibility |
Implantable Devices |
Bone screws, pacemakers |
Internal tissues/bloodstream |
Long-term |
Full biological eval, systemic toxicity, implantation |
Medical device engineers and designers working with 3D printed parts for healthcare should establish these classifications early to avoid costly redesigns or regulatory delays. This is particularly important for those choosing between USP Class VI 3D printing plastics and ISO 13485-compliant materials.
Sterilizability refers to a material’s ability to endure sterilization procedures without compromising its safety, mechanical integrity, or functionality. In medical applications, any device that enters a sterile field—or touches the patient directly—must undergo validated sterilization methods that are compatible with both the material and the design.
Common Sterilization Methods Include:
Method |
Description |
Notes |
Ethylene Oxide (EtO) |
Low-temperature gas sterilization |
Effective for heat-sensitive parts |
Autoclave (Steam) |
High-pressure steam (~120°C) |
Can warp or weaken some plastics |
Gamma Irradiation |
High-energy radiation to sterilize packaging |
Used for high-throughput batches |
Vaporized Hydrogen Peroxide (VhP) |
Low-temp sterilization for delicate parts |
Best for parts with fine features |
Important: Some sterile 3D printing materials only tolerate a limited number of sterilization cycles. For example:
For teams evaluating sterilized 3D printed components or producing sterilizable surgical tools with AM, verifying compatibility early can help reduce failures and rework.
Each material reacts differently to sterilization methods. A polymer that works well in dry environments may soften, warp, or release harmful residues when exposed to high heat or aggressive chemicals. That’s why sterilization compatibility must be confirmed in parallel with biocompatibility testing.
Proper validation of sterilization also includes post-sterilization performance assessments, ensuring that mechanical properties, surface finish, and dimensional accuracy remain intact.
Even if a material is fully biocompatible off the printer, how it is post-processed, handled, and finished can make or break its medical safety. It is possible—and unfortunately common—for a printed part to lose its biocompatibility due to contamination introduced after printing.
Biocompatibility is not guaranteed by the printer or the material—it must be maintained through every step of the process. That’s why working with ISO 13485 compliant providers -- like Stratasys Direct – is crucial to ensuring that each step in the manufacturing process meets the highest regulatory standards.
A validated post-processing workflow ensures that every step of production, from print to final packaging, preserves the material’s certified biocompatibility. This includes:
This ensures 3D printed parts maintain performance and pass quality inspections. These protocols are essential for anyone using additive manufacturing for medical devices.
Stratasys Direct offers a wide portfolio of biocompatible 3D printing materials suitable for medical, dental, and surgical applications, across multiple additive manufacturing technologies:
Technology |
Material |
Use Case |
Certifications |
Sterilization Compatibility |
PolyJet |
MED610, MED615 |
Surgical guides, oral trays |
ISO 10993-5, -10, -3 |
EtO, VhP |
|
Vero (indirect use) |
Display or mock-up tools |
Limited (non-contact) |
EtO (selective), not autoclave |
SLA |
Somos® BioClear |
Diagnostic models, pre-surgical |
ISO 10993-5, -10, -11 |
EtO, Gamma |
FDM |
PC-ISO |
Functional tools, surgical fixtures |
ISO 10993, USP Class VI |
EtO, Gamma, Autoclave |
|
ABS-M30i |
Surgical trays, brackets |
ISO 10993, USP Class VI |
EtO, Gamma |
|
Ultem™ 1010 |
High-temp surgical housings |
ISO 10993, FDA food contact |
Autoclave |
P3 |
MED413 |
Dental tools, surgical guides |
ISO 10993-5, -10, -11, -23, -18 |
EtO, Gamma, Autoclave |
SAF |
PA12 |
Braces, splints, casings |
ISO 10993-5, -10, -11, -23, -18 |
EtO, Gamma |
Selecting the right combination of printing technology, material, and post-processing approach depends on the end use of the part, the required tolerances, and patient safety requirements.
Medical device manufacturers preparing for FDM submission must provide evidence of:
For medical devices made with 3D printing, it's crucial to consider material selection early in the design process. To ensure your device is safe for human use, you should align with standards like ISO 10993 and FDA expectations from the start.
This early alignment is important because the duration and type of patient contact (e.g., surface contact versus surgical contact with bone or blood) directly influence your choice of materials and printing technology. Documenting these decisions and material selections is a required part of the device master record. This documentation is essential for streamlining your 510(k) or PMA submissions to the FDA, which are required to prove your device's safety and get it approved for market.
Biocompatibility and sterilization are essential pillars of safe medical 3D printing. While selecting a certified material is an important first step, how the part is handled after printing is just as critical. From support removal to sterilization validation, every step in the post-processing workflow must maintain the part’s compliance, integrity, and readiness for clinical use.
To produce reliable medical devices with 3D printing, manufacturers must:
Whether you’re designing surgical tools, dental appliances, or wearable components, successful medical additive manufacturing relies on safety, regulatory discipline, and material knowledge.
Biocompatible 3D printing isn’t just about what a material can do—it’s about what it should do, and how you ensure it performs as intended every step of the way.